Treating major depression in primary care practice: An update of the agency for health care policy and research practice guidelines

Archives of General Psychiatry

Volumn 55, Issue 12, 1998, Pages 1121-1127

  Schulberg, Herbert C ^a,e   Katon, Wayne ^b   Simon, Gregory E ^b,c   Rush, A John ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; HETEROCYCLIC COMPOUND; IMIPRAMINE; LOFEPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG EFFICACY; FOLLOW UP; HEALTH CARE POLICY; HUMAN; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PSYCHOTHERAPY;

EID: 0031769035     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.12.1121     Document Type: Article

References (77)

1. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care. Volume 2: Treatment of Major Depression. Rockville, Md: US Dept of Health and Human Services Agency for Health Policy and Research; 1993. AHCPR publication 93-0550.
2. American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am J Psychiatry. 1993;150(suppl):S1-S26.
3. Brown J, Shye D, McFarland B. The paradox of guideline implementation: how AHCPR's depression guideline was adapted at Kaiser Permanente Northwest Region. Jt Comm J Qual Improv. 1995;21:5-21.
4. Kathol R, Katon W, Smith G, Petty R, Trivedi M, Rush A. Guidelines for the diagnosis and treatment of depression for primary care physicians: implications for consultation-liaison psychiatrists. Psychosomatics. 1994;35:1-12.
5. Schulberg H, Rush A. Clinical practice guidelines for managing maior depression in primary care practice: implications for psychologists. Am Psychol. 1994;48:34-41.
6. Nathan P. Practice guidelines: not yet ideal. Am Psychol. 1998;53:290-299.
7. Grimshaw J, Russell I. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317-1322.
8. Tunis S, Hayward R, Wilson M, Rubin H, Bass E, Johnston M, Steinberg E. Internists' attitudes about clinical practice guidelines. Ann Intern Med. 1994; 120:956-963.
9. Grilli R, Lomas J. Evaluating the message: the relationship between compliance rate and the subject of a practice guideline. Med Care. 1994;32: 202-213.
10. Gifford F. Outcomes research and practice guidelines: upstream issues for downstream users. Hastings Cent Rep. 1996;26:38-44.
11. Munoz R, Hollon S, McGrath E, Rehm L, Vanden-Bos G. On the AHCPR Depression in Primary Care Guidelines: further considerations for practitioners. Am Psychol. 1994;48:42-61.
12. Klein D. The utility of guidelines and algorithms for practice. Psychiatr Ann. 1994;24:362-367.
13. Persons J, Thase M, Christoph P. The role of psychotherapy in the treatment of depression: review of two practice guidelines. Arch Gen Psychiatry. 1996;53:283-290.
14. Rush A. Research and clinical practice: bridging the gap. Curr Opin Psychiatry. 1994;7:3-4.
15. Trivedi M, Smith H, Rush A. Efficacy of antidepressants in primary care: a meta-analysis. Primary Care Psychiatry. In press.
16. Moon C, Vince M. Treatment of major depression in general practice. Br J Clin Pract. 1996;50: 240-244.
17. Ravindran A, Judge R, Hunter B, Bray J, Morton H, Paroxetine Study Group. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. J Clin Psychiatry. 1997;58:112-118.
18. Schulberg H, Block MR, Madonia MJ, Scott C, Rodriguez E, Imber S, Perel J, Lave J, Houck P, Coulehan JL. Treating major depression in primary care practice: eight-month clinical outcomes. Arch Gen Psychiatry. 1996;53:913-919.
19. Simon G, Von Korff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, Wagner EH. Initial antidepressant selection in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1897-1902.
20. Kupfer D, Frank E, Perel J, Cornes C, Mallinger A, Thase M, McEachran A, Grochocinski V. Five-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1992; 49:769-773.
21. Lin EHB, Katon WJ, Von Korff M, Russo JE, Simon GE, Bush TM, Rutter CM, Walker EA, Ludman E. Relapse of depression in primary care: rate and clinical predictors. Arch Fam Med. 1998;7: 443-449.
22. Liebowitz M, Quitkin F, Stewart J, McGrath P, Harrison W, Rabkin J, Tricamo E, Markowitz J, Klein D. Phenelzine vs imipramine in atypical depression: a preliminary report. Arch Gen Psychiatry. 1984;41:669-677.
23. Quitkin F, McGrath P, Stewart J, Harrison W, Tricamo E, Wager S, Ocepek-Welikson K, Nunes E, Rabkin J, Klein D. Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry. 1990;47: 935-941.
24. Quitkin F, Stewart J, McGrath P, Liebowitz M, Harrison W, Tricamo E, Klein D, Rabkin J, Markowitz J, Wager S. Phenelzine versus imipramine in the treatment of probably atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry. 1988;145:305-311.
25. Donoghue J, Typee A, Wildgust H. Cross-sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-1995. BMJ. 1996;313:861-862.
26. MacDonald T, McMahan A, Reid G, Fenton H, McDevitt D. Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ. 1996;313:860-861.
27. Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67-76.
28. Simon G, Von Korff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15:399-408.
29. Montgomery S, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol. 1995;9(suppl 4):33-40.
30. Anderson I, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ. 1995;310:1433-1438.
31. Song F, Freemantle N, Sheldon T, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ. 1993;306:683-687.
32. Fairman K, Teitelbaum F, Drevets W, Engquist G, Kreisman J, Norusis M. Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments. Am J Managed Care. 1997;3: 453-465.
33. McFarland BH. Cost-effectiveness considerations for managed care systems: treating depression in primary care. Am J Med. 1994;97 (Suppl 6A):47S-57S.
34. Jonsson B, Bebbington PE. What price depression: the cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry. 1994;164:665-673.
35. LePen C, Levy E, Ravily V, Beuzen JN, Meurgey F. The cost of treatment dropout in depression: a cost-benefit analysis of fluoxetine vs tricyclics. J Affect Disord. 1994;31:1-18.
36. Montgomery S, Brown RE, Clark M. Economic analysis of treating depression with nefazodone v imipramine. Br J Psychiatry. 1996;168: 768-771.
37. Revicki D, Brown RE, Keller MB, Gonzales J, Culpepper L, Hales RE. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. J Clin Psychiatry. 1997;58:47-58.
38. Sclar O, Robison LM, Skaer TL, Legg RF, Nemec NL, Galin RS, Hughes TE, Buesching KP. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther. 1994;16:715-730.
39. Forder J, Kavanagh S, Fenyo A. A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care. J Affect Disord. 1996;38:97-111.
40. Croghan T, Lair T, Engelhart L, Crown W, Copley-Merriman C, Melfi C, Obenchain R, Bueschling D. Effect of antidepressant therapy on health care utilization and costs in primary care. Psychiatr Serv. 1997;48:1420-1426.
41. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, Simon G, Walker E. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53: 924-932.
42. Katon W, Von Korff M, Lin E, Walker E, Simon G, Bush T, Robinson P, Russo J. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273: 1026-1031.
43. Schulberg H, Block M, Madonia M, Scott C, Lave J, Rodriguez E, Coulehan J. The "usual care" of major depression in primary care practice. Arch Fam Med. 1997;6:334-339.
44. Scott A, Freeman C. Edinburgh Primary Care Depression Study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ. 1992; 304:883-887.
45. Mynors-Wallis L, Gath DH, Lloyd-Thomas AR, Tomlinson D. Randomised controlled trial comparing problem-solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995;310:441-445.
46. Catalan J, Gath D, Anastasiades P, Bond S, Day A, Hall L. Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med. 1991;21:1013-1018.
47. Mynors-Wallis L. Problem-solving treatment: evidence for effectiveness and feasibility in primary care. Int J Psychiatry Med. 1996;26: 249-262.
48. Lynch D, Tamburrino M, Nagel R. Telephone counseling for patients with minor depression: preliminary findings in a family practice setting. J Fam Pract. 1997;44:293-298.
49. Elkin I, Gibbons R, Shea M, Sotsky S, Watkins J, Pilkonis P, Hedeker D. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1995;63:841-847.
50. Mynors-Wallis L, Gath D. Predictors of treatment outcome for major depression in primary care. Psychol Med. 1997;27:731-736.
51. Schulberg H, Pilkonis P, Houck P. The severity of major depression and choice of treatment in primary care practice. J Consult Clin Psychol. In press.
52. Brown C, Schulberg H. The efficacy of psychosocial treatments in primary care: a review of randomized clinical trials. Gen Hosp Psychiatry. 1995; 17:414-424.
53. Blackburn I, Bishop S, Glen A, Whalley L, Christie J. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry. 1981;139:181-189.
54. Kovacs M, Rush A, Beck A, Hollon S. Depressed outpatients treated with cognitive therapy or pharmacotherapy: a one-year follow-up. Arch Gen Psychiatry. 1981;38:33-39.
55. Thase M, Greenhouse J, Frank E, Reynolds C, Pilkonis P, Hurley K, Grochocinski J, Kupfer D. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54: 1009-1015.
56. Quitkin F, McGrath P, Stewart J, Ocepek-Welikson K, Taylor B, Nunes E, Deliyannides D, Agosti V, Donovan S, Petkova E, Klein D. Chronological milestones to guide drug change. Arch Gen Psychiatry. 1996;53:785-792.
57. Nierenberg A, McLean N, Alpert J, Worthington J, Rosenbaum J, Fava M. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry. 1995;152:1500-1503.
58. Katz M, Koslow S, Frazer A. Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs. Depress Anxiety. 1996-1997;4:257-267.
59. Rush A, Clayton P. Galle B, Baron D, Bernstein L, De Wester J, Evans D, Matchett C, Nemeroff C, Phillips K, Susman J. Consensus Conference: Length of Antidepressant Therapy. Little Falls, NJ: Health Learning Systems; 1996.
60. Katon W, Von Korff M, Lin E, Unutzer J, Simon G, Walker E, Ludman E, Bush T. Population-based care of depression: effective disease management strategies to decrease prevalence. Gen Hosp Psychiatry. 1997;19:169-178.
61. Katzelnick D, Simon G, Manning W, Henk H, Pearson S, Helstad C. Treatment of depressed high utilizers in three HMOs. Paper presented at: American Psychiatric Association Annual Meeting: June 2, 1998; Toronto, Ontario.
62. Dowrick C, Buchan I. Twelve-month outcome of depression in general practice: does detection or disclosure make a difference? BMJ. 1995;311: 1274-1277.
63. Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL, Tierney WM. Improving treatment of late-life depression in primary care: a randomized clinical trial. J Am Geriatr Soc. 1994;42:839-846.
64. Goldberg HI, Wagner EH, Fihn SD, Martin DP, Horowitz CR, Christensen DB, Cheadle AD, Diehr P, Simon G. A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines? Jt Comm J Qual Improv. 1998;24:130-142.
65. Lin EHB, Katon WJ, Simon GE, Von Korff M, Bush TM, Rutter CM, Saunders KW, Walker EA. Achieving guidelines for treatment of depression in primary care: is physician education enough? Med Care. 1997;35:831-842.
66. Schulberg H, Block MR, Madonia MJ, Rodriguez E, Scott P, Lave J. Applicability of clinical guideline pharmacotherapy for major depression in primary care settings. Arch Fam Med. 1995;4:106-112.
67. Clarkin J, Pilkonis P, Magruder K. Psychotherapy of depression: implications for reform of the health care system. Arch Gen Psychiatry. 1996; 53:717-723.
68. Borenstein D. Does managed care permit appropriate use of psychotherapy? Psychiatr Serv. 1996; 47:971-974.
69. Meredith L, Wells KB, Kaplan SH, Mazel RM. Counseling typically provided for depression: role of clinician specialty and payment system. Arch Gen Psychiatry. 1996;53:905-912.
70. Von Korff M, Katon W, Lin E, Saunders K, Simon G, Walker E, Robinson P, Bush T. Evaluation of cost and cost offset of collaborative management of depressed patients in primary care. Psychosomatics. 1998;60:143-149.
71. Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry .1998;55:645-651.
72. Sturm R, Wells KB. How can care for depression become more cost-effective? JAMA. 1995;273:51-58.
73. Simon G, Ormel J, Von Korff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152:352-357.
74. Simon G, Von Korff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52:850-856.
75. Henk H, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch Gen Psychiatry. 1996;53:899-904.
76. Von Korff M, Ustun T, Ormel J, Kaplan I, Simon G. Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol. 1996;49:297-303.
77. Spitzer R, Kroenke K, Linzer M, Hahn SR, Williams JBW, deGruy FV, Brody D, Davies M. Health-related quality of life in primary care patients with mental disorders. JAMA. 1995;274:1511-1517.